Thyroid Adenocarcinoma: Mutation Analysis (MutSig vS2N)
(tall-cell cohort)
Maintained by Dan DiCara (Broad Institute)
Overview
Introduction

This report serves to describe the mutational landscape and properties of a given individual set, as well as rank genes and genesets according to mutational significance. MutSig vS2N was used to generate the results found in this report.

  • Working with individual set: THCA-tall-cell

Input

The input for this pipeline is a set of individuals with the following files associated for each:

  1. An annotated .maf file describing the mutations called for the respective individual, and their properties.

  2. A .wig file that contains information about the coverage of the sample.

Summary
Results
Significantly Mutated Genes

Column Descriptions:

  • N = number of sequenced bases in this gene across the individual set

  • nnon = number of (nonsilent) mutations in this gene across the individual set

  • nnull = number of (nonsilent) null mutations in this gene across the individual set

  • nflank = number of noncoding mutations from this gene's flanking region, across the individual set

  • nsil = number of silent mutations in this gene across the individual set

  • p = p-value (overall)

  • q = q-value, False Discovery Rate (Benjamini-Hochberg procedure)

Table 1.  Get Full Table A Ranked List of Significantly Mutated Genes. Number of significant genes found: 0. Number of genes displayed: 35. Click on a gene name to display its stick figure depicting the distribution of mutations and mutation types across the chosen gene (this feature may not be available for all significant genes).

gene N nflank nsil nnon nnull p q
BRAF 6003 0 0 21 0 0 0
TG 22627 0 1 3 2 1 1
TTN 293246 0 1 3 1 1 1
ZNF28 5917 0 0 3 0 1 1
ARID1B 12532 0 0 2 1 1 1
COL6A2 6244 0 0 2 0 1 1
CT45A5 940 0 0 2 0 1 1
DBN1 4163 0 0 2 0 1 1
FANCD2 13188 0 0 2 0 1 1
KIF2C 6121 0 0 2 0 1 1
MYOM2 11902 0 0 2 0 1 1
NAV3 18567 0 0 2 0 1 1
SETX 23144 0 0 2 0 1 1
TOPBP1 12069 0 0 2 0 1 1
TRPM4 7130 0 0 2 0 1 1
A2M 11211 0 0 1 0 1 1
ABCA3 12117 0 0 1 0 1 1
ABCB11 10470 0 0 1 0 1 1
ABCB7 5856 0 0 1 1 1 1
ABCD1 3387 0 0 1 0 1 1
ACAD10 8148 0 0 1 1 1 1
ACOT12 4442 0 0 1 0 1 1
ACVR2A 4353 0 0 1 0 1 1
ADAM33 3304 0 0 1 1 1 1
ADAMTS18 9266 0 0 1 0 1 1
ADAMTSL3 13041 0 0 1 0 1 1
ADAMTSL4 6038 0 0 1 0 1 1
ADC 3631 0 0 1 0 1 1
ADH7 3200 0 0 1 0 1 1
AIM1 12839 0 0 1 0 1 1
AMOTL2 4571 0 0 1 0 1 1
ANAPC5 6348 0 0 1 0 1 1
ANK2 30498 0 0 1 0 1 1
AP2B1 8122 0 0 1 0 1 1
AP3B1 9511 0 0 1 0 1 1
Methods & Data
Methods

In brief, we tabulate the number of mutations and the number of covered bases for each gene. The counts are broken down by mutation context category: four context categories that are discovered by MutSig, and one for indel and 'null' mutations, which include indels, nonsense mutations, splice-site mutations, and non-stop (read-through) mutations. For each gene, we calculate the probability of seeing the observed constellation of mutations, i.e. the product P1 x P2 x ... x Pm, or a more extreme one, given the background mutation rates calculated across the dataset. [1]

Download Results

This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.

References
[1] TCGA, Integrated genomic analyses of ovarian carcinoma, Nature 474:609 - 615 (2011)